CB Technologies Opens London Office; European Demand for MetaTrial(TM) Prompts New Office

Apr 19, 2001, 01:00 ET from CB Technologies, Inc.

    WEST CHESTER, Pa., April 19 /PRNewswire/ -- With a rapidly growing base of
 European clients, investigator sites, and global partnerships, CB
 Technologies, Inc. -- the premier provider of clinical electronic data capture
 (EDC) software and services -- today announces it is opening a London office.
 This office will provide clients with services, technical support, and
 training for CB's clinical trial technology solutions including MetaTrial(TM)
 software.
     "Opening this office is the natural next step in our client-focused
 strategy," says James L. Coyne, CEO of CB Technologies.  "Through this
 location, we will be able to fully support our growing number of key clients
 throughout Europe."
     CB's MetaTrial provides the most flexible EDC platform available and has
 become the gold standard solution for reliable, secure, easy-to-use EDC.  With
 hybrid and thin-client architectures that work in concert, clients can select
 the solution that best suits each site within a study.  This is particularly
 important for global studies where some sites may not have a consistently
 reliable Internet connection.  CB's myMetaTrial portal is a powerful web
 portal essential for tracking and managing clinical studies.
 
     About CB Technologies, Inc.
     CB Technologies, Inc. is a leading provider of Electronic Clinical
 Intelligence(TM) tools and services for the life science industries.  CB is
 headquartered in Philadelphia with offices in Boston, New York, Charleston,
 San Francisco, San Diego, and London.  For more information visit CB's website
 at www.cbtech.com or www.metatrial.com.
     CB Technologies, MetaTrial, Electronic Clinical Intelligence, and eCI are
 trademarks of CB Technologies, Inc.  All other company names and products may
 be the property of their respective owners.
 
 

SOURCE CB Technologies, Inc.
    WEST CHESTER, Pa., April 19 /PRNewswire/ -- With a rapidly growing base of
 European clients, investigator sites, and global partnerships, CB
 Technologies, Inc. -- the premier provider of clinical electronic data capture
 (EDC) software and services -- today announces it is opening a London office.
 This office will provide clients with services, technical support, and
 training for CB's clinical trial technology solutions including MetaTrial(TM)
 software.
     "Opening this office is the natural next step in our client-focused
 strategy," says James L. Coyne, CEO of CB Technologies.  "Through this
 location, we will be able to fully support our growing number of key clients
 throughout Europe."
     CB's MetaTrial provides the most flexible EDC platform available and has
 become the gold standard solution for reliable, secure, easy-to-use EDC.  With
 hybrid and thin-client architectures that work in concert, clients can select
 the solution that best suits each site within a study.  This is particularly
 important for global studies where some sites may not have a consistently
 reliable Internet connection.  CB's myMetaTrial portal is a powerful web
 portal essential for tracking and managing clinical studies.
 
     About CB Technologies, Inc.
     CB Technologies, Inc. is a leading provider of Electronic Clinical
 Intelligence(TM) tools and services for the life science industries.  CB is
 headquartered in Philadelphia with offices in Boston, New York, Charleston,
 San Francisco, San Diego, and London.  For more information visit CB's website
 at www.cbtech.com or www.metatrial.com.
     CB Technologies, MetaTrial, Electronic Clinical Intelligence, and eCI are
 trademarks of CB Technologies, Inc.  All other company names and products may
 be the property of their respective owners.
 
 SOURCE  CB Technologies, Inc.